Celgene: KarMMa-3 Ph3 Randomized bb2121 vs Standard regimen in RRMM (Multiple Myeloma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about how about the study drug (bb2121) affects people with relapsed and refractory multiple myeloma compared to standard treatment.
Relapsed and Refractory Multiple Myeloma
Who Can Participate in the Study?
Adults who have Relapsed/Refractory Multiple Myeloma
What is Involved?
If you chose to be in the study you will:
- Have a physical exam
- Take a memory test
- Give blood and urine samples
- Complete questionnaires
- Be randomized (like flipping a coin) to take the study drug bb2121 or the standard treatment
- Get x-rays of body